Thompson Davis & Co., Inc. Stereotaxis, Inc. Transaction History
Thompson Davis & Co., Inc.
- $159 Million
- Q4 2025
A detailed history of Thompson Davis & Co., Inc. transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 25,199 shares of STXS stock, worth $55,689. This represents 0.03% of its overall portfolio holdings.
Number of Shares
25,199Holding current value
$55,689% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding STXS
# of Institutions
114Shares Held
43.1MCall Options Held
13.8KPut Options Held
31.4K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30.2 Million11.38% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.71MShares$10.4 Million8.41% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$7.6 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$6.31 Million10.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $165M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...